We’re on a mission to accelerate global drug launches.

Every pharmaceutical drug launch is a uniquely complex endeavour. Before patients can access novel treatments, pharmaceutical manufacturers need to carefully analyze gigabytes of messy, fragmented data, create thousands of pages of regulatory documents, determine global launch sequences, and so much more. Historically, this complexity has inevitably resulted in multiple years of necessary preparation.

Our mission is to accelerate global pharmaceutical drug launches. By automating repetitive workflows on top of our robust data foundation, we help pharmaceutical companies bring life-saving treatments to patients faster than ever before.

Founders

Cellbyte founders Felix Steinbrenner, Daniel Moreira and Samuel Moreira

Felix Steinbrenner

Co-CEO

Daniel Moreira

Co-CEO

Samuel Moreira

CTO

Advisors

Stefan Kilian

Former Corporate Vice President Market Access, Pricing and HEOR

Boehringer Ingelheim

Troy Dale

Former Head Commercial, Strategic Partnerships Unit (VP)

Novartis

Romain Marcel

Former General Manager, EMEA CP&C

Veeva Systems

Backed by world-class investors

Y Combinator Frontline Ventures Pace Ventures

Saras Capital

Springboard Health.

Angels

Newsroom

Press releases and partnership announcements

Raising $2.75M from Frontline Ventures Nov 18, 2025

Startup in spotlight: Cellbyte zips $2.75M to cut pharma drug launch times Nov 18, 2025

Cellbyte raises $2.75 million to cut pharmaceutical drug launch timelines in half with AI Nov 18, 2025

Join our team

View Open Roles →

Home Platform Services Customers Security Company

We’re on a mission to accelerate global drug launches.

Every pharmaceutical drug launch is a uniquely complex endeavour. Before patients can access novel treatments, pharmaceutical manufacturers need to carefully analyze gigabytes of messy, fragmented data, create thousands of pages of regulatory documents, determine global launch sequences, and so much more. Historically, this complexity has inevitably resulted in multiple years of necessary preparation.

Our mission is to accelerate global pharmaceutical drug launches. By automating repetitive workflows on top of our robust data foundation, we help pharmaceutical companies bring life-saving treatments to patients faster than ever before.

Founders

Cellbyte founders Felix Steinbrenner, Daniel Moreira and Samuel Moreira
Felix Steinbrenner
Co-CEO
Daniel Moreira
Co-CEO
Samuel Moreira
CTO

Advisors

Stefan Kilian
Former Corporate Vice President Market Access, Pricing and HEOR
Boehringer Ingelheim
Troy Dale
Former Head Commercial, Strategic Partnerships Unit (VP)
Novartis
Romain Marcel
Former General Manager, EMEA CP&C
Veeva Systems

Backed by world-class investors

Y Combinator Frontline Ventures Pace Ventures Saras Capital Springboard Health. Angels
Y Combinator Frontline Ventures Pace Ventures
Saras Capital Springboard Health. Angels

Newsroom

Press releases and partnership announcements

Felix, Daniel and Samuel, co-founders of Cellbyte
Raising $2.75M from Frontline Ventures
Nov 18, 2025
Tech Funding News
Startup in spotlight: Cellbyte zips $2.75M to cut pharma drug launch times
Nov 18, 2025
FirstWord Pharma
Cellbyte raises $2.75 million to cut pharmaceutical drug launch timelines in half with AI
Nov 18, 2025

Join our team

View Open Roles →